Multi-Cancer Early Detection Test Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

Multi-Cancer Early Detection Test Market: By Technology (cfDNA Methylation, Fragmentomics, Protein Biomarker Panels, Multi-Analyte/Combined); Test Purpose (Population Screening, High-Risk Screening, Diagnostic Aid); Channel (Laboratory-Developed Tests, FDA-Approved/IVD, Direct-to-Consumer); Payer (Self-Pay, Commercial Insurance, Government/Medicare, Employer Programs); End User (Health Systems, Physician Practices, Employers & Consumers)— Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035

The multi-cancer early detection (MCED) test market is estimated at USD 600.5 million in 2025 and is projected to reach USD 13,986 million by 2035, growing at a CAGR of 37.0% over the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 01-Sep-2026  |  Format:  |  Report ID: AA09261955